ArticleWorld journal of gastrointestinal surgery2025
Endoscopic hemostasis combined with vascular interventional therapy for acute nonvariceal upper gastrointestinal bleeding: A meta-analysis.
Article in World journal of gastrointestinal surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transcatheter arterial embolization with N-butyl cyanoacrylate versus gelatin sponge particles for gastric cancer-related upper gastrointestinal bleeding: a comparison of efficacy and safety.Journal of gastrointestinal oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute nonvariceal upper gastrointestinal bleeding (NVUGIB) is a life-threatening emergency. Endoscopic hemostasis and vascular interventional therapy are two major minimally invasive treatment strategies. Although these modalities are widely used, their comparative efficacy and safety across different patient populations and anatomical sites remain controversial.
aimTo evaluate the clinical outcomes and safety of endoscopic hemostasis combined with vascular interventional therapy for NVUGIB.
methodsA systematic search was done on PubMed, EMBASE, Cochrane Library, and Web of Science (from database establishment to April 2025). Randomized controlled trial (RCT) quality was assessed
resultsTwenty-one studies (3 RCTs, 12 single-group studies, and 6 retrospective cohort studies) with good quality were included. For single-group data, combined therapy had risk differences of 0.70 (clinical success), 0.24 (mortality), and 0.22 (rebleeding; all
conclusionCombined endoscopic hemostasis and vascular interventional therapy for acute NVUGIB can significantly reduce rebleeding, without differences in mortality. Age and vascular interventional methods may influence the therapeutic efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.